Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
10.56 SEK | +5.81% | -0.19% | +213.35% |
05-07 | Transcript : Ascelia Pharma AB - Special Call | |
05-02 | Ascelia Pharma AB Successfully Meets Primary Endpoint with Strong Headline Results in Orvigance Phase 3 Study | CI |
- Stock Market
- Equities
- ACE Stock
- News Ascelia Pharma AB
- Transcripts